Citations

Clear

75 citation(s) found for "Starlinger, P".

Intrahepatic neutrophil accumulation and extracellular trap formation are associated with posthepatectomy liver failure
Brunnthaler, Laura, Brenner, M, Herrmann, Lukas , Schrottmaier, Waltraud C. , Pirabe, Anita , Schmuckenschlager, Anna , Kern, A.E. , Huber, Felix Xaver, Michels, Lisa Emilie, Salzmann, Manuel , Hohensinner, Philipp J. , Kain, Renate , Pereyra, David , Brenner, Miriam, Santol, Jonas , Herrmann, Lukas, Kim, Sarang , Brostjan, Christine , Gruenberger, Thomas , Starlinger, Patrick , Assinger, Alice

Mayo Clinic

Hepatology Communications | December 15, 2023 | Volume: 8 | Issue: 1 | Pages: No page available

10.1097/hc9.0000000000000348 | PMID 38099865 Get It

Background: Posthepatectomy liver failure (PHLF) represents a life-threatening complication with limited therapeutic options. Neutrophils play a critical and dynamic role during regeneratory processes, but their role in human liver regeneration is incompletely understood, especially as underlying liver disease, detectable in the majority of patients, critically affects hepatic regeneration. Here we explored intrahepatic neutrophil accumulation and neutrophil extracellular traps (NETs) in patients with PHLF and validated the functional relevance of NETs in a murine partial hepatectomy (PHx) model. Methods: We investigated the influx of neutrophils, macrophages, eosinophils, and mast cells and the presence of their respective extracellular traps in liver biopsies of 35 patients undergoing hepatectomy (10 patients with PHLF) before and after the initiation of liver regeneration by fluorescence microscopy. In addition, NET formation and neutrophil activation were confirmed by plasma analysis of 99 patients (24 patients with PHLF) before and up to 5 days after surgery. Furthermore, we inhibited NETs via DNase I in a murine PHx model of mice with metabolically induced liver disease. Results: We detected rapid intrahepatic neutrophil accumulation, elevated levels of myeloperoxidase release, and NET formation in regenerating human livers, with a significantly higher increase of infiltrating neutrophils and NETs in patients with PHLF. Circulating markers of neutrophil activation, including elastase, myeloperoxidase, and citrullinated histone H3, correlated with markers of liver injury. In a murine PHx model, we showed that the inhibition of NET accelerated hepatocyte proliferation and liver regeneration. Conclusions: Patients with PHLF showed accelerated intrahepatic neutrophil infiltration and NET formation, which were associated with liver damage. Further, we identified postsurgical myeloperoxidase levels as predictive markers for adverse outcomes and observed that blocking NETs in a murine PHx model accelerated tissue regeneration.
An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure
Santol, Jonas , Gregory, Lindsey A., Baumgartner, Ruth , Birgin, Emrullah , Gloor, Severin , Braunwarth, Eva , Ammann, M. , Starlinger, Johannes , Ammon, Daphni , Ninkovic, Marijana , Kern, Anna , Rumpf, Benedikt , Ortmayr, Gregor , Herrmann, Yannic, Huber, Felix Xaver, Weninger, Jeremias, Smoot, Rory L. , Truty, Mark J. , Kendrick, Michael L. , Nagorney, David M. , Rahbari, Nuh N. , Hoffmann, Katrin , Hackl, Hubert , Maier, Eva , Smoot, Rory L , Hackl, Hubert , Santol, Jonas , Ammann, Markus , Kim, Sarang , Murtha-Lemekhova, Anastasia , Pereyra, David , Kern, Anna E., Dong, Yawen , Thiels, Cornelius A. , Warner, Susanne G. , Cleary, Sean P. , Beldi, Guido , Gilg, Stefan , Assinger, Alice , Gruenberger, Thomas , Starlinger, Patrick

Mayo Clinic

Annals of Surgery | October 20, 2023 | Volume: 281 | Issue: 5 | Pages: 861-871

10.1097/sla.0000000000006127 | PMID 37860868 Get It

Objective and Background: Clinically significant posthepatectomy liver failure (PHLF B+C) remains the main cause of mortality after major hepatic resection. This study aimed to establish an aspartate aminotransferase to platelet ratio combined with an albumin-bilirubin grade (APRI+ALBI), based multivariable model (MVM) to predict PHLF and compare its performance to indocyanine green clearance (ICG-R15 or ICG-PDR) and albumin-ICG evaluation (ALICE). Methods: A total of 12,056 patients from the National Surgical Quality Improvement Program database were used to generate a MVM to predict PHLF B+C. The model was determined using stepwise backwards elimination. The performance of the model was tested using receiver operating characteristic curve analysis and validated in an international cohort of 2525 patients. In 620 patients, the APRI+ALBI MVM, trained in the National Surgical Quality Improvement Program cohort, was compared with the MVM’s based on other liver function tests (ICG clearance, ALICE) by comparing the areas under the curve (AUC). Results: A MVM including APRI+ALBI, age, sex, tumor type, and extent of resection was found to predict PHLF B+C with an AUC of 0.77, with comparable performance in the validation cohort (AUC: 0.74). In direct comparison with other MVM’s based on more expensive and time-consuming liver function tests (ICG clearance, ALICE), the APRI+ALBI MVM demonstrated equal predictive potential for PHLF B+C. A smartphone application for the calculation of the APRI+ALBI MVM was designed. Conclusion: Risk assessment through the APRI+ALBI MVM for PHLF B+C increases preoperative predictive accuracy and represents a universally available and cost-effective risk assessment before hepatectomy, facilitated by a freely available smartphone app.
The role of microRNAs in the different phases of liver regeneration
Kern, A.E. , Ortmayr, Gregor , Assinger, Alice , Kern, Anna Emilia , Assinger, Alice , Starlinger, Patrick

Mayo Clinic

Expert Review of Gastroenterology & Hepatology | October 9, 2023 | Volume: 17 | Issue: 10 | Pages: 959-973

10.1080/17474124.2023.2267422 | PMID 37811642 Get It

The Role of the Multiparametric MRI LiverMultiScanTM in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis
Chouari, Tarak , Merali, Nabeel , Costa, Francesca La, Chapman, Shelley, Horton, Alex, Aroori, Somaiah , Connell, John , Rockall, Timothy , Welsh, Fenella K.S., Rees, Myrddin, Frampton, Adam E. , Connell, John , Frampton, Adam E , Santol, Jonas , Chapman, Shelley, Mole, Damian J. , Starlinger, Patrick

Mayo Clinic

Cancers | October 6, 2023 | Volume: 15 | Issue: 19 | Pages: 4863

10.3390/cancers15194863 | PMID 37835557 Get It

Liver biopsy remains the gold standard for the histological assessment of the liver. With clear disadvantages and the rise in the incidences of liver disease, the role of neoadjuvant chemotherapy in colorectal liver metastasis (CRLM) and an explosion of surgical management options available, non-invasive serological and imaging markers of liver histopathology have never been more pertinent in order to assess liver health and stratify patients considered for surgical intervention. Liver MRI is a leading modality in the assessment of hepatic malignancy. Recent technological advancements in multiparametric MRI software such as the LiverMultiScanTM offers an attractive non-invasive assay of anatomy and histopathology in the pre-operative setting, especially in the context of CRLM. This narrative review examines the evidence for the LiverMultiScanTM in the assessment of hepatic fibrosis, steatosis/steatohepatitis, and potential applications for chemotherapy-associated hepatic changes. We postulate its future role and the hurdles it must surpass in order to be implemented in the pre-operative management of patients undergoing hepatic resection for colorectal liver metastasis. Such a role likely extends to other hepatic malignancies planned for resection.
Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection
Zhang, Chi , Gudmundsdottir, Hallbera , Takahashi, Hiroaki , Day, Courtney N. , Glasgow, Amy E. , Wasif, Nabil , Grotz, Travis E. , Smoot, Rory L. , Truty, Mark J. , Kendrick, Michael L. , Nagorney, David M. , Grotz, Travis E , Truty, Mark, Cleary, Sean, Kendrick, Michael, Nagorney, David, Navin, Patrick, Thiels, Cornelius A , Smoot, Rory L , Gudmundsdottir, Hallbera , Takahashi, Hiroaki , Starlinger, Patrick , Warner, Susanne G. , Cleary, Sean P. , Navin, Patrick J. , Hálfdánarson, Þorvarður R. , Thiels, Cornelius A.

Mayo Clinic

Journal of Surgical Oncology | August 2, 2023 | Volume: 128 | Issue: 7 | Pages: 1072-1079

10.1002/jso.27413 | PMID 37529970 Get It

AbstractBackground and ObjectivesWe assessed the accuracy of preoperative gallium‐68 DOTA‐Tyr3‐octreotate (DOTATATE) positron emission tomography (PET) imaging in estimating multifocality and nodal metastases of small bowel neuroendocrine tumors (sbNETs).MethodsA multicenter analysis was performed on patients with sbNETs who underwent preoperative DOTATATE PET imaging and surgical resection, with manual palpation of the entire length of the small bowel, between January 2016 and August 2022. Preoperative imaging reports and blinded secondary imaging reviews were compared to the final postoperative pathology reports. Descriptive statistics were applied.ResultsOne‐hundred and four patients met inclusion criteria. Pathology showed 53 (51%) patients had multifocal sbNETs and 96 (92%) had nodal metastases. The original preoperative DOTATATE PET imaging identified multifocal sbNET in 28 (27%) patients and lymph node (LN) metastases in 80 (77%) patients. Based on original radiology reports, sensitivity for multifocal sbNET identification was 45%, specificity was 92%, positive predictive value (PPV) was 86%, and negative predictive value (NPV) was 62%. For the identification of LN metastases, sensitivity was 82%, specificity was 88%, PPV was 99%, and NPV was 29%.ConclusionsAlthough DOTATATE PET imaging is specific and relatively accurate, sensitivity and NPV are insufficient to guide surgical planning. Preoperative use should not replace open palpation to identify additional synchronous lesions or to omit regional lymphadenectomy.
Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy
Zhang, Chi , Smoot, Rory L. , Kendrick, Michael L. , Truty, Mark J. , Zironda, Andrea , Kendrick, Michael, Cleary, Sean, Truty, Mark, Smoot, Rory L , Vierkant, Robert A. , Starlinger, Patrick , Warner, Susanne G. , Cleary, Sean P. , Thiels, Cornelius A.

Mayo Clinic

Annals of Surgery | July 27, 2023 | Volume: 279 | Issue: 5 | Pages: 842-849

10.1097/sla.0000000000006053 | PMID 37497660 Get It

Objective: To describe long-term quality of life (QOL) and gastrointestinal (GI) symptoms in patients who underwent pancreatoduodenectomy for pancreatic cancer in the modern era. Background: As advances in pancreatic cancer management improve outcomes, it is essential to assess long-term patient-reported outcomes after surgery. Methods: Patients who underwent curative intent pancreatoduodenectomy for pancreatic cancer between January 2011 and June 2019 from a single center were identified. Patients alive ≥3 years after surgery were considered long-term survivors (LTS). LTS who were alive in June 2022 received a 55-question survey to assess their QOL (EORTC-QLQ-C30) and GI symptoms (EORTC-PAN26 and Problem Areas in Diabetes Questionnaire). Responses were compared against population norms. Clinicodemographic characteristics in LTS versus non-LTS and survey completion were compared. Results: Six hundred seventy-two patients underwent pancreatoduodenectomy for pancreatic cancer; 340 were LTS. One hundred thirty-seven patients of the 238 eligible to complete the survey responded (response rate: 58%). Compared to the US general population, LTS reported significantly higher QOL (75 vs 64; P<0.001), less nausea/vomiting, pain, dyspnea, insomnia, appetite loss, and constipation, but more diarrhea (all P<0.001). Most patients (n=136/137, 99%) reported experiencing postoperative GI symptoms related to pancreatic insufficiency (n=71/135, 53%), reflux (n=61/135, 45%), and delayed gastric emptying (n=31/136, 23%). Most patients (n=113/136, 83%) reported that digestive symptoms overall had little to no impact on QOL, and 91% (n=124/136) would undergo surgery again. Conclusions: Despite known long-term complications following pancreatoduodenectomy, cancer survivors appear to have excellent QOL. Specific long-term gastrointestinal symptoms data should be utilized for preoperative education and follow-up planning.
E-AHPBA–ESSO–ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy
Primavesi, Florian , Maglione, Manuel , Cipriani, Federica , Denecke, Timm , Oberkofler, Christian E. , Dasari, B. , Heil, Jan , Sgarbură, Olivia , Søreide, Kjetil , Díaz-Nieto, Rafael, Geisel, Dominik , Henninger, Benjamin , Hessheimer, Amelia J. , Mole, Damian J. , Reiberger, Thomas , Schnitzbauer, Andreas A. , Sparrelid, Ernesto , Stockmann, Martin , Truant, Stéphanie , Aldrighetti, Luca , Braunwarth, Eva , D’Hondt, Mathieu , DeOliveira, Michelle L., Erdmann, Joris I. , Kaczirek, Klaus , Malik, Hassan , Öfner, Dietmar , Rahbari, Nuh N. , Göbel, Georg , Siriwardena, Ajith K. , Dasari, Bobby V M , Sgarbura, Olivia , Søreide, Kjetil , Lesurtel, Mickaël , Mole, Damian , Schnitzbauer, Andreas A , Aldrighetti, Luca , Erdmann, Joris I , Gruenberger, Thomas , Öfner, Dietmar , Siriwardena, Ajith K , Maier, Eva , Reiberger, Thomas , Cipriani, Federica , Oberkofler, Christian , Maglione, Manuel , Starlinger, Patrick , Fondevila, Constantino , Frampton, Adam E. , Lesurtel, Mickaël , Öllinger, Robert , Olthof, Pim , Schwarz, Christoph C. , Fuks, David , Gruenberger, Thomas , Stättner, Stefan

Mayo Clinic

British Journal of Surgery | July 20, 2023 | Volume: 110 | Issue: 10 | Pages: 1331-1347

10.1093/bjs/znad233 | PMID 37572099 Get It

Abstract Background Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus guidelines provide guidance for preoperative patient assessment. Methods A modified Delphi approach was used to achieve consensus. The expert panel consisted of hepatobiliary surgeons, radiologists, nuclear medicine specialists, and hepatologists. The guideline process was supervised by a methodologist and reviewed by a patient representative. A systematic literature search was performed in PubMed/MEDLINE, the Cochrane library, and the WHO International Clinical Trials Registry. Evidence assessment and statement development followed Scottish Intercollegiate Guidelines Network methodology. Results Based on 271 publications covering 4 key areas, 21 statements (at least 85 per cent agreement) were produced (median level of evidence 2− to 2+). Only a few systematic reviews (2++) and one RCT (1+) were identified. Preoperative liver function assessment should be considered before complex resections, and in patients with suspected or known underlying liver disease, or chemotherapy-associated or drug-induced liver injury. Clinical assessment and blood-based scores reflecting liver function or portal hypertension (for example albumin/bilirubin, platelet count) aid in identifying risk of PHLF. Volumetry of the future liver remnant represents the foundation for assessment, and can be combined with indocyanine green clearance or LiMAx® according to local expertise and availability. Functional MRI and liver scintigraphy are alternatives, combining FLR volume and function in one examination. Conclusion These guidelines reflect established methods to assess preoperative liver function and PHLF risk, and have uncovered evidence gaps of interest for future research.
Glucagon-like peptide-1 and glucagon-like peptide-2 are potential regulators of lipid metabolism during human liver regeneration
Kalchbrenner, Tamara, Wuerger, Tanja, Hulla, Wolfgang , Laengle, Friedrich, Ammann, M. , Santol, Jonas , Pereyra, David , Laengle, Johannes , Smoot, Rory L. , Starlinger, Patrick

Mayo Clinic

No container title available | July 17, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3136257/v1 Get It

Abstract Accumulating evidence suggests that metabolic demands of the regenerating liver are met via lipid metabolism and critical regulators of this process. As such, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) critically affect hepatic regeneration in rodent models. The present study aimed to evaluate potential alterations and dynamics of circulating GLP-1 and GLP-2 in patients undergoing liver resections, focusing on post-hepatectomy liver failure (PHLF). GLP-1, GLP-2, Interleukin-6 (IL-6) and parameters of lipid metabolism were determined perioperatively in fasting plasma of 46 patients, who underwent liver resection. GLP-1 and GLP-2 demonstrated a rapid and consistently inverse time course during hepatic regeneration with a significant decrease of GLP-1 and increase of GLP-2 on POD1. Importantly, these postoperative dynamics were significantly more pronounced when PHLF occurred. Of note, the extent of resection or development of complications were not associated with these alterations. IL-6 mirrored the time course of GLP-2. Assessing the main degradation protein dipeptidyl peptidase 4 (DPP4) no significant association with either GLP-1 or -2 could be found. Additionally, in PHLF distinct postoperative declines in plasma lipid parameters were present and correlated with GLP-2 dynamics. Our data suggest dynamic inverse regulation of GLP-1 and GLP-2 during liver regeneration, rather caused by an increase in expression/release than by changes in degradation capacity and might be associated with inflammatory responses. Their close association with circulating markers of lipid metabolism and insufficient hepatic regeneration after liver surgery suggest a critical involvement during these processes in humans.
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Kartik, Akash , Müller, Catharina , Acs, Miklos , Piso, Pompiliu , Grotz, Travis E. , Grotz, Travis E , Starlinger, Patrick , Bachleitner‐Hofmann, Thomas

Mayo Clinic

Pleura and Peritoneum | June 1, 2023 | Volume: 8 | Issue: 3 | Pages: 113-121

10.1515/pp-2022-0203 | PMID 37662605 Get It

Abstract Objectives Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is associated with significant postoperative complications. Early detection of at-risk patients may lead to improved outcomes. The role of C-reactive protein (CRP) in predicting postoperative complications has only been recently investigated. Methods Postoperative complications were categorized according to Clavien-Dindo classification and further divided into minor (Grade <3) and major complications (Grade ≥3A). Absolute CRP counts (mg/L) on postoperative days (POD) 1–7, and proportional change in CRP was compared and the area under (AUC) receiver operating characteristics (ROC) curve was calculated. Univariate and multivariate analysis was performed. Significant findings were externally validated. Results Twenty-five percent of patients experienced one or more major complications. A CRP level of ≥106 mg/L on POD 2 and 65.5 mg/L on POD 4 were significantly associated with an increased risk of major complications with an AUC of 0.658 and 0.672, respectively. The proportional increase in CRP between POD 1 and 4 (ΔCRP POD 1/4) at a cut-off of 30 % had the best AUC of 0.744 and was the only independent risk factor for major complications (p<0.0001) on multivariate analysis. ∆CRP had an AUC of 0.716 (p=0.002) when validated in an independent database. Conclusions CRP can be used in a variety of ways to predict major complications after CRS and HIPEC. However, the ∆CRP POD 1/4>30 % is the best indicator of major complications. Serial CRP measurements in the early postoperative period may lead to early detection of patients at risk of major complications allowing for alternative management strategies to improve outcomes.
Technical Outcomes of Porto-Mesenteric Venous Reconstruction in Pancreatic Resection Using Autologous Left Renal Vein Graft as Conduit
Abdelrahman, Amro M. , Lynch, Isaac T. , Smoot, Rory L. , Kendrick, Michael L. , Truty, Mark J. , Fogliati, Alessandro, Smoot, Rory L , Abdelrahman, Amro M , Fogliati, Alessandro , Fiorentini, Guido , Alva‐Ruiz, Roberto , Zironda, Andrea , Starlinger, Patrick , Cleary, Sean P.

Mayo Clinic

Journal of the American College of Surgeons | May 9, 2023 | Volume: 237 | Issue: 1 | Pages: 58-67

10.1097/xcs.0000000000000744 | PMID 37158471 Get It

BACKGROUND: Portal or superior mesenteric vein (PV-SMV) resection and reconstruction is sometimes required during pancreatic tumor resection. In patients requiring segmental venous resection with interposition grafting, the left renal vein (LRV) is an accessible autologous solution. However, long-term patency outcomes of the LRV as an interposition conduit in this setting have not been analyzed. STUDY DESIGN: We conducted a retrospective analysis of patients undergoing pancreatic resection with PV-SMV reconstruction using LRV between 2002 and 2022. The primary outcome was PV-SMV patency at last follow-up, assessed with postoperative CT scans and analyzed using Kaplan-Meier survival methods that account for variation in follow-up duration. Development of any postoperative acute kidney injury within 7 days of surgery and morbidity were secondary outcomes. RESULTS: The study cohort includes 65 patients who underwent LRV harvest; 60 (92%) ultimately underwent successful reconstruction with harvested LRV graft. Kaplan-Meier 2-year estimated patency rate of the LRV graft was 88%, with no cases of complete occlusion. Six (10%) patients experienced graft stenosis. Nine of 61 (15%) patients experienced grade II or III acute kidney injury, 6 of 9 returning to normal renal function before discharge. No difference in median serum creatinine was observed at baseline, 6 and 12 months from surgery. LRV remnant thrombosis was seen in 7 of 65 (11%) patients. Only 3 of 61 (5%) patients had persistent acute kidney injury caused by complications unrelated to LRV harvesting. CONCLUSIONS: Autologous LRV graft was a reliable conduit for segmental PV-SMV reconstruction, resulting in a high patency rate and marginal impact on renal function. LRV harvest is a safe and potentially ideal surgical option for PV-SMV reconstruction in pancreatic surgery.